Novartis Dividends
| NVS Stock | USD 158.20 1.15 0.73% |
Dividends Paid is likely to drop to about 5.3 B in 2026. Dividend Yield is likely to drop to 0.02 in 2026. Novartis' past performance could be the main factor of why investors trade Novartis AG ADR stock today. Investors should clearly understand every aspect of the Novartis dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Novartis' dividend schedule and payout information. Novartis AG ADR dividends can also provide a clue to the current valuation of Novartis.
Number Of Dividends | Years Issued 27 | Previous Year 1 Times | Current Year 1 Times | Year Average 1 | Volatility 0.0 |
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 7.9 B | 5.3 B | |
| Dividend Yield | 0.03 | 0.02 | |
| Dividend Payout Ratio | 0.56 | 0.41 | |
| Dividend Paid And Capex Coverage Ratio | 2.04 | 1.87 |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Novartis must own a stock before its ex-dividend date to receive its next dividend.
Novartis Dividends Paid Over Time
Today, most investors in Novartis Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Novartis' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Novartis dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Novartis Historical Dividend Yield Growth
A solid dividend growth pattern of Novartis could indicate future dividend growth is likely, which can signal long-term profitability for Novartis AG ADR. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period. Dividend Yield is Novartis AG ADR dividend as a percentage of Novartis stock price. Novartis AG ADR dividend yield is a measure of Novartis stock productivity, which can be interpreted as interest rate earned on an Novartis investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Dividend Yield |
| Timeline |
Novartis Past Distributions to stockholders
Is there potential for Pharmaceuticals market expansion? Will Novartis introduce new products? Factors like these will boost the valuation of Novartis. Anticipated expansion of Novartis directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Novartis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.12) | Dividend Share 4.666 | Earnings Share 7.15 | Revenue Per Share | Quarterly Revenue Growth 0.022 |
Understanding Novartis AG ADR requires distinguishing between market price and book value, where the latter reflects Novartis's accounting equity. The concept of intrinsic value - what Novartis' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Novartis' price substantially above or below its fundamental value.
It's important to distinguish between Novartis' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Novartis should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Novartis' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.